
Cit Plus 500mg/800mg Tablet
Marketer
Claris Lifesciences Ltd
Salt Composition
Citicoline (500mg) + Piracetam (800mg)
Overview Cit Plus 500mg/800mg Tablet
NeuroMend 500mg/800mg tablets aid in stroke recovery and cognitive enhancement. This medication safeguards brain cells from damage and promotes their repair, also finding application in brain injury treatment. NeuroMend 500mg/800mg can be administered with or without food, ideally at the same time daily for consistent blood levels. Follow your physician's prescribed dosage and duration; if a dose is missed, take it immediately upon recall. Complete the entire course, even with symptom improvement, and never discontinue use abruptly without consulting your doctor as this could exacerbate symptoms. Common, typically transient side effects include restlessness, abdominal discomfort, anxiety, and hypotension. Should these persist or prove troublesome, seek medical advice. Maintain adequate hydration while using NeuroMend, as diarrhea may occur. Weight gain is possible; manage this through a balanced diet and regular exercise.
Primary Ingredients of Cit Plus 500mg/800mg Tablet
No text provided. Please provide the text you want me to rephrase.
Uses of Cit Plus 500mg/800mg Tablet
Stroke Recovery Program
Major Benefits of Cit Plus 500mg/800mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Cit Plus 500mg/800mg tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, although consistent daily timing is recommended.
Common Side effects of Cit Plus 500mg/800mg Tablet:
- Weight gain
- Hyperactivity
- Stomach pain
- Nervousness
- Diarrhea
- Decreased blood pressure
- Uncoordinated body movements
- Dizziness
How to use Cit Plus 500mg/800mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the 500mg/800mg Cit Plus tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable; however, consistent daily timing is recommended.
How Cit Plus 500mg/800mg Tablet works:
CogniPlus 500mg/800mg tablets combine citicoline and piracetam to support brain health. Citicoline, a neuroprotective agent, fosters neuronal nourishment, safeguarding against cellular damage and enhancing viability. Piracetam, a GABAergic compound, offers neuroprotection against hypoxic conditions while modulating ion channel activity within neuronal membranes.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Cit Plus 500mg/800mg tablets lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Cit Plus 500mg/800mg tablets in pregnancy are lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Cit Plus 500mg/800mg tablets while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Cit Plus 500mg/800mg Tablet, which can induce drowsiness and tremor. Side effects from Cit Plus 500mg/800mg Tablet may compromise safe driving.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Cit Plus 500mg/800mg tablets, as dosage modification may be necessary. A physician's consultation is advised. Cit Plus 500mg/800mg tablets are contraindicated in individuals with severe kidney disease.
LiverSAFE IF PRESCRIBED
The use of Cit Plus 500mg/800mg tablets in patients with liver disease appears to pose minimal risk. Existing evidence indicates that dose modification may not be necessary for this patient group. However, physician consultation is advised.
What if you forget to take Cit Plus 500mg/800mg Tablet :
Should you forget a Cit Plus 500mg/800mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cit Plus 500mg/800mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
